Inhibition of chemical mediator release from human leukocytes by a new antiasthma drug, HC 20-511 (ketotifen).
D000941:Antigens; D001249:Asthma / Q000188:drug therapy*; D000001:Calcimycin / Q000494:pharmacology; D004205:Cromolyn Sodium / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D007962:Leukocytes / Q000187:drug effects*; D009504:Neutrophils / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D013189:SRS-A / Q000378:metabolism; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use*
D000941:Antigens; D010880:Piperidines; D013189:SRS-A; D013876:Thiophenes; D007073:Immunoglobulin E; D000001:Calcimycin; D004205:Cromolyn Sodium